select a format

Single User License
USD 1500 INR 97485
Site License
USD 3000 INR 194970
Corporate User License
USD 4500 INR 292455

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


Bionor Pharma ASA-Product Pipeline Review-2015

Bionor Pharma ASA-Product Pipeline Review-2015


  • Products Id :- GMDHC07207CDB
  • |
  • Pages: 37
  • |
  • July 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Bionor Pharma ASA-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Bionor Pharma ASA-Product Pipeline Review-2015', provides an overview of the Bionor Pharma ASA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bionor Pharma ASA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Bionor Pharma ASA including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Bionor Pharma ASA's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Bionor Pharma ASA's pipeline products

Reasons To Buy

Evaluate Bionor Pharma ASA's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Bionor Pharma ASA in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Bionor Pharma ASA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Bionor Pharma ASA and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bionor Pharma ASA

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Bionor Pharma ASA and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Bionor Pharma ASA Snapshot 5

Bionor Pharma ASA Overview 5

Key Information 5

Key Facts 5

Bionor Pharma ASA-Research and Development Overview 6

Key Therapeutic Areas 6

Bionor Pharma ASA-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Combination Treatment Modalities 10

Bionor Pharma ASA-Pipeline Products Glance 11

Bionor Pharma ASA-Clinical Stage Pipeline Products 11

Phase II Products/Combination Treatment Modalities 11

Phase I Products/Combination Treatment Modalities 12

Bionor Pharma ASA-Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Discovery Products/Combination Treatment Modalities 14

Bionor Pharma ASA-Drug Profiles 15

Vacc-4x 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Vacc-C5 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Vacc-4x + Vacc-C5 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Vacc-Flu 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Vacc-HCV 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Vacc-CMV 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Vacc-HPV 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Bionor Pharma ASA-Pipeline Analysis 26

Bionor Pharma ASA-Pipeline Products by Route of Administration 26

Bionor Pharma ASA-Pipeline Products by Molecule Type 27

Bionor Pharma ASA-Recent Pipeline Updates 28

Bionor Pharma ASA-Company Statement 33

Bionor Pharma ASA-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Appendix 36

Methodology 36

Coverage 36

Secondary Research 36

Primary Research 36

Expert Panel Validation 36

Contact Us 36

Disclaimer 37

List of Tables

Bionor Pharma ASA, Key Information 5

Bionor Pharma ASA, Key Facts 5

Bionor Pharma ASA-Pipeline by Indication, 2015 7

Bionor Pharma ASA-Pipeline by Stage of Development, 2015 8

Bionor Pharma ASA-Monotherapy Products in Pipeline, 2015 9

Bionor Pharma ASA-Combination Treatment Modalities in Pipeline, 2015 10

Bionor Pharma ASA-Phase II, 2015 11

Bionor Pharma ASA-Phase I, 2015 12

Bionor Pharma ASA-Preclinical, 2015 13

Bionor Pharma ASA-Discovery, 2015 14

Bionor Pharma ASA-Pipeline by Route of Administration, 2015 26

Bionor Pharma ASA-Pipeline by Molecule Type, 2015 27

Bionor Pharma ASA-Recent Pipeline Updates, 2015 28

Bionor Pharma ASA, Other Locations 35

Bionor Pharma ASA, Subsidiaries 35

List of Figures

Bionor Pharma ASA-Pipeline by Top 10 Indication, 2015 7

Bionor Pharma ASA-Pipeline by Stage of Development, 2015 8

Bionor Pharma ASA-Monotherapy Products in Pipeline, 2015 9

Bionor Pharma ASA-Pipeline by Top 10 Route of Administration, 2015 26

Bionor Pharma ASA-Pipeline by Top 10 Molecule Type, 2015 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Bionor Pharma ASA; Bionor Pharma ASA - Key Therapeutics; Bionor Pharma ASA - Pipeline Overview and Promising Molecules; Bionor Pharma ASA - News; Bionor Pharma ASA - Latest Updates; Bionor Pharma ASA - Pipeline; Bionor Pharma ASA - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com